We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.16B
AUM Growth
+$235M
Cap. Flow
+$21.9M
Cap. Flow %
1.01%
Top 10 Hldgs %
37.62%
Holding
102
New
26
Increased
22
Reduced
15
Closed
27

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$157M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$34.1M
3
NVRO
NEVRO CORP.
NVRO
+$28.6M
4
GILD icon
Gilead Sciences
GILD
+$28.1M
5
PEN icon
Penumbra
PEN
+$26.9M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$92.8M
2
MCK icon
McKesson
MCK
+$50.5M
3
CAH icon
Cardinal Health
CAH
+$45.2M
4
LH icon
Labcorp
LH
+$30.8M
5
BAX icon
Baxter International
BAX
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 67.91%
2 Technology 4.93%
3 Consumer Discretionary 1.42%
4 Industrials 0.78%
5 Utilities 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
51
Aptiv
APTV
$9.61B
$13.8M 0.64%
150,794
+13,037
+9% +$1.09M
NEE icon
52
NextEra Energy
NEE
$176B
$13.1M 0.61%
188,604
+106,324
+129% +$7.34M
DVAX
53
DELISTED
Dynavax Technologies
DVAX
$12.7M 0.59%
2,936,990
+1,793,464
+157% +$12.8M
IOVA icon
54
Iovance Biotherapeutics
IOVA
$2.77B
$12.6M 0.58%
+381,990
New +$11.7M
RVMD icon
55
Revolution Medicines
RVMD
$42.4B
$12.5M 0.58%
+360,313
New +$9.98M
RNAM
56
DELISTED
Avidity Biosciences
RNAM
$11M 0.51%
+441,155
New +$12.7M
KRTX
57
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$10.7M 0.49%
137,960
-214,585
-61% -$18.3M
ITOS
58
DELISTED
iTeos Therapeutics
ITOS
$10M 0.46%
+406,467
New +$10.9M
SHOP icon
59
Shopify
SHOP
$190B
$9.67M 0.45%
94,540
– –
MYOV
60
DELISTED
Myovant Sciences Ltd.
MYOV
$8.83M 0.41%
+628,272
New +$11.7M
V icon
61
Visa
V
$692B
$8.69M 0.4%
43,468
– –
MRNA icon
62
PUT
Moderna
MRNA
$21.5B
$8.49M 0.39%
+120,000
New +$8.37M
ALLO icon
63
Allogene Therapeutics
ALLO
$680M
$8.46M 0.39%
+224,266
New +$8.46M
ST icon
64
Sensata Technologies
ST
$6.74B
$8.35M 0.39%
+193,585
New +$7.87M
LAB icon
65
Standard BioTools
LAB
$314M
$7.85M 0.36%
1,056,343
-867,729
-45% -$5.99M
LONA
66
LeonaBio Inc
LONA
$73.4M
$7.25M 0.34%
+39,249
New +$6.56M
ZEN
67
DELISTED
ZENDESK INC
ZEN
$6.9M 0.32%
67,034
– –
ADAP
68
DELISTED
Adaptimmune Therapeutics
ADAP
$6.78M 0.31%
+849,440
New +$7.43M
RCUS icon
69
CALL
Arcus Biosciences
RCUS
$3.61B
$4.11M 0.19%
+240,000
New +$5.36M
AMWL icon
70
American Well
AMWL
$220M
$3.85M 0.18%
+6,500
New +$3.43M
ALNA
71
DELISTED
Allena Pharmaceuticals
ALNA
$421K 0.02%
284,285
– –
ABBV icon
72
CALL
AbbVie
ABBV
$431B
– –
-366,800
Closed -$36M
BAX icon
73
Baxter International
BAX
$14B
– –
-295,222
Closed -$25.4M
CAH icon
74
CALL
Cardinal Health
CAH
$55.7B
– –
-500,000
Closed -$26.1M
CAH icon
75
Cardinal Health
CAH
$55.7B
– –
-865,933
Closed -$45.2M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q3 2020 Portfolio in Review

As of Q3 2020, PFM Health Sciences held 102 positions worth $2.16B, up 12% from $1.93B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PFM Health Sciences's Q3 2020 filing shows 26 new, 22 increased, 15 reduced and 27 closed positions. Its largest new stake was Outset Medical: 191,533 shares worth $131M. The largest sale was Immunomedics Inc, an estimated $92.8M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 67% a quarter earlier, followed by Technology and Consumer Discretionary.

  • PFM Health Sciences's largest Q3 2020 buy was Outset Medical: 191,533 shares worth $131M.
  • PFM Health Sciences added most to NEVRO CORP. in Q3 2020, an estimated $28.6M increase.
  • PFM Health Sciences's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $92.8M.
  • PFM Health Sciences fully exited McKesson in Q3 2020, selling an estimated $50.5M.
  • PFM Health Sciences's ten largest holdings make up 38% of its $2.16B portfolio in Q3 2020.
  • PFM Health Sciences opened 26 new positions and closed 27 in Q3 2020.
  • PFM Health Sciences's portfolio value rose 12% quarter-over-quarter to $2.16B.

Based on PFM Health Sciences's 13F filing for Q3 2020, filed 16 Nov 2020.